Published in Anesth Analg on June 01, 1996
Sympathetic hyperactivity during desflurane anesthesia in healthy volunteers. A comparison with isoflurane. Anesthesiology (1993) 3.55
Assessment of clinical skills of residents utilizing standardized patients. A follow-up study and recommendations for application. Ann Intern Med (1991) 3.23
Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotype. Clin Pharmacol Ther (2011) 3.09
Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants. Clin Pharmacol Ther (2013) 2.38
Rehydration of desiccated Baralyme prevents carbon monoxide formation from desflurane in an anesthesia machine. Anesthesiology (1997) 2.06
Endotracheal flumazenil: a new route of administration for benzodiazepine antagonism. Am J Emerg Med (1998) 2.04
Bispectral index monitoring during sedation with sevoflurane, midazolam, and propofol. Anesthesiology (2001) 1.58
Absence of biochemical evidence for renal and hepatic dysfunction after 8 hours of 1.25 minimum alveolar concentration sevoflurane anesthesia in volunteers. Anesthesiology (1998) 1.54
Comparison of sevoflurane/fentanyl and isoflurane/fentanyl during elective coronary artery bypass surgery. Sevoflurane Venture Group. Can J Anaesth (1996) 1.51
Sympathetic responses to induction of anesthesia in humans with propofol or etomidate. Anesthesiology (1992) 1.51
Chronic epidural bupivacaine-opioid infusion in intractable cancer pain. Pain (1992) 1.44
Contribution of CYP2E1 and CYP3A to acetaminophen reactive metabolite formation. Clin Pharmacol Ther (2000) 1.44
Is the Combitube a useful emergency airway device for anesthesiologists? Anesth Analg (1998) 1.42
Cost-effective reduction of neuromuscular-blocking drug expenditures. Anesthesiology (1997) 1.39
Change in stroke volume by iced temperature injectate for thermodilution cardiac output determination. Anesthesiology (1993) 1.38
Psychedelic effects of ketamine in healthy volunteers: relationship to steady-state plasma concentrations. Anesthesiology (1998) 1.31
Nasal administration of opioids for pain management in adults. Acta Anaesthesiol Scand (2002) 1.29
Neurocirculatory responses to sevoflurane in humans. A comparison to desflurane. Anesthesiology (1995) 1.17
Contribution of itraconazole metabolites to inhibition of CYP3A4 in vivo. Clin Pharmacol Ther (2007) 1.14
Increased frequency of a null-allele for NAD(P)H: quinone oxidoreductase in patients with urological malignancies. Pharmacogenetics (1997) 1.14
Gender differences in drug effects: implications for anesthesiologists. Acta Anaesthesiol Scand (2003) 1.13
Influence of cardiac output on dexmedetomidine pharmacokinetics. J Pharm Sci (2000) 1.13
Cardiovascular responses to sevoflurane: a review. Anesth Analg (1995) 1.13
In-vivo phenotyping for CYP3A by a single-point determination of midazolam plasma concentration. Pharmacogenetics (2001) 1.12
Mechanisms whereby propofol mediates peripheral vasodilation in humans. Sympathoinhibition or direct vascular relaxation? Anesthesiology (1997) 1.10
The conservative treatment of osteonecrosis of the femoral head. A comparison of core decompression and pulsing electromagnetic fields. Clin Orthop Relat Res (1989) 1.10
Glucose metabolism in human malignant gliomas measured quantitatively with PET, 1-[C-11]glucose and FDG: analysis of the FDG lumped constant. J Nucl Med (1998) 1.09
Regional P-glycoprotein activity and inhibition at the human blood-brain barrier as imaged by positron emission tomography. Clin Pharmacol Ther (2010) 1.08
Intracellular magnesium does not antagonize calcium-dependent acetylcholine secretion. J Physiol (1981) 1.05
Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy, and drug interactions. Drug Metab Dispos (1997) 1.05
Hypoxia imaging-directed radiation treatment planning. Eur J Nucl Med Mol Imaging (2006) 1.04
Lowered amounts of the tissue-specific transcription factor LFB1 (HNF1) correlate with decreased levels of glutathione S-transferase alpha messenger RNA in human renal cell carcinoma. Cancer Res (1994) 1.00
Acute renal failure after cardiopulmonary bypass in related to decreased serum ferritin levels. J Am Soc Nephrol (1999) 1.00
Expression of NAD(P)H:quinone oxidoreductase and glutathione S-transferases alpha and pi in human renal cell carcinoma and in kidney cancer-derived cell lines. Carcinogenesis (1994) 1.00
Does ketamine-mediated N-methyl-D-aspartate receptor antagonism cause schizophrenia-like oculomotor abnormalities? Neuropsychopharmacology (1998) 0.94
Mechanistic aspects of carbon monoxide formation from volatile anesthetics. Anesthesiology (1998) 0.92
Speed of recovery and side-effect profile of sevoflurane sedation compared with midazolam. Anesthesiology (2001) 0.92
Interleukin-6 serum levels in healthy persons correspond to the sleep-wake cycle. Clin Investig (1994) 0.90
Kinetic quantitation of cerebral PET-FDG studies without concurrent blood sampling: statistical recovery of the arterial input function. IEEE Trans Med Imaging (2009) 0.90
A meta-analysis of CYP2D6 metabolizer phenotype and metoprolol pharmacokinetics. Clin Pharmacol Ther (2013) 0.90
Cytochrome P450 2E1 is the principal catalyst of human oxidative halothane metabolism in vitro. J Pharmacol Exp Ther (1997) 0.90
Nephrotoxicity of sevoflurane compound A [fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether] in rats: evidence for glutathione and cysteine conjugate formation and the role of renal cysteine conjugate beta-lyase. Biochem Biophys Res Commun (1995) 0.89
Metabolism of dapsone to its hydroxylamine by CYP2E1 in vitro and in vivo. Clin Pharmacol Ther (1995) 0.89
Human renal cell carcinogenesis is accompanied by a coordinate loss of the tissue specific transcription factors HNF4 alpha and HNF1 alpha. Cancer Lett (1996) 0.89
Determination of cardiac output using ensemble-averaged impedance cardiograms. J Appl Physiol (1985) (1985) 0.89
Loss of HNF1alpha function in human renal cell carcinoma: frequent mutations in the VHL gene but not the HNF1alpha gene. Mol Carcinog (1999) 0.88
Alfentanil modifies the neurocirculatory responses to desflurane. Anesth Analg (1996) 0.87
Duration of cytochrome P-450 2E1 (CYP2E1) inhibition and estimation of functional CYP2E1 enzyme half-life after single-dose disulfiram administration in humans. J Pharmacol Exp Ther (1999) 0.86
p53 immunohistochemistry as a prognostic marker in bladder cancer. Playground for urology scientists? Eur Urol (2000) 0.86
Human halothane reduction in vitro by cytochrome P450 2A6 and 3A4: identification of low and high KM isoforms. Drug Metab Dispos (1998) 0.86
Determining hypoxic fraction in a rat glioma by uptake of radiolabeled fluoromisonidazole. Radiat Res (2000) 0.85
Positron emission tomography imaging of tissue P-glycoprotein activity during pregnancy in the non-human primate. Br J Pharmacol (2009) 0.85
[Treatment strategy in first traumatic anterior dislocation of the shoulder. Plea for a multi-stage concept of preventive initial management]. Unfallchirurg (1998) 0.85
Propofol and autonomic reflex function in humans. Anesth Analg (1994) 0.85
Human liver microsomal enflurane defluorination catalyzed by cytochrome P-450 2E1. Drug Metab Dispos (1993) 0.85
Metabolism of methadone and levo-alpha-acetylmethadol (LAAM) by human intestinal cytochrome P450 3A4 (CYP3A4): potential contribution of intestinal metabolism to presystemic clearance and bioactivation. J Pharmacol Exp Ther (2001) 0.85
Comparison of renal function following anesthesia with low-flow sevoflurane and isoflurane. J Clin Anesth (1999) 0.84
Neurocirculatory responses to intubation with either an endotracheal tube or laryngeal mask airway in humans. J Clin Anesth (1996) 0.84
Interaction of GLP-I and leptin at rat pancreatic B-cells: effects on insulin secretion and signal transduction. Horm Metab Res (1997) 0.84
Fluvoxamine-theophylline interaction: gap between in vitro and in vivo inhibition constants toward cytochrome P4501A2. Clin Pharmacol Ther (2001) 0.84
c-myc in bladder cancer. Clinical findings and analysis of mechanism. Urol Res (1997) 0.84
Molecular imaging of regional brain tumor biology. J Cell Biochem Suppl (2002) 0.84
Kinetic analysis of 2-[11C]thymidine PET imaging studies: validation studies. J Nucl Med (1999) 0.84
Deoxyglucose kinetics in a rat brain tumor. J Cereb Blood Flow Metab (1989) 0.83
Prevalence of thyroid cancer in hyperthyroid patients treated by surgery. World J Surg (1998) 0.83
Effects of fentanyl on sympathetic activation associated with the administration of desflurane. Anesthesiology (1995) 0.83
Unilateral carotid sinus stimulation and muscle sympathetic nerve activity in man. Med Sci Sports Exerc (1996) 0.83
Blood flow changes following 137Cs irradiation in a rat glioma model. Radiat Res (1988) 0.82
P53 accumulation in precursor lesions and early stages of bladder cancer. World J Urol (1994) 0.82
Propofol, but not etomidate, reduces desflurane-mediated sympathetic activation in humans. Can J Anaesth (1999) 0.82
A pilot evaluation of alfentanil-induced miosis as a noninvasive probe for hepatic cytochrome P450 3A4 (CYP3A4) activity in humans. Clin Pharmacol Ther (2001) 0.81
Inhibition of sulfamethoxazole hydroxylamine formation by fluconazole in human liver microsomes and healthy volunteers. Clin Pharmacol Ther (1996) 0.81
FHIT expression in clear cell renal carcinomas: versatility of protein levels and correlation with survival. J Pathol (2002) 0.81
Immunocytology in the assessment of patients with asymptomatic hematuria. World J Urol (2007) 0.80
Mitoxantrone: propensity for free radical formation and lipid peroxidation--implications for cardiotoxicity. Invest New Drugs (1985) 0.80
The molecular basis for complexation of adriamycin with flavin mononucleotide and flavin adenine dinucleotide. Arch Biochem Biophys (1981) 0.80
[Reproducibility of Doppler ultrasonography in the study of hepatic blood flow]. Radiol Med (1994) 0.80
p53 and MDM2 in the development and progression of bladder cancer. Eur Urol (1997) 0.79
Halothane-dependent lipid peroxidation in human liver microsomes is catalyzed by cytochrome P4502A6 (CYP2A6). Anesthesiology (2001) 0.79
Lack of effect of cimetidine on acetaminophen disposition in humans. Clin Pharmacol Ther (1989) 0.79
Bis(alkylamino)anthracenedione antineoplastic agent metabolic activation by NADPH-cytochrome P-450 reductase and NADH dehydrogenase: diminished activity relative to anthracyclines. Arch Biochem Biophys (1983) 0.79
Major histocompatibility complex class I and class II expression in renal cell carcinoma and modulation by interferon gamma. J Urol (1996) 0.79
Identification in rat bile of glutathione conjugates of fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether, a nephrotoxic degradate of the anesthetic agent sevoflurane. Chem Res Toxicol (1996) 0.79
Nutrition and prostate cancer. Urol Int (2001) 0.79
Catalytic role of cytochrome P4503A4 in multiple pathways of alfentanil metabolism. Drug Metab Dispos (1995) 0.78
Acute tolerance and reversal of the motor control effects of midazolam. Pharmacol Biochem Behav (1998) 0.78
Impedance-derived cardiac indices in supine and upright exercise. Ann Biomed Eng (1989) 0.78
Transition to post-operative epidural or patient-controlled intravenous analgesia following total intravenous anaesthesia with remifentanil and propofol for abdominal surgery. Eur J Anaesthesiol (1997) 0.78
Nitrofurantoin-stimulated proteolysis in human erythrocytes: a novel index of toxic insult by nitroaromatics. J Pharmacol Exp Ther (1988) 0.78
Metabolism of levo-alpha-Acetylmethadol (LAAM) by human liver cytochrome P450: involvement of CYP3A4 characterized by atypical kinetics with two binding sites. J Pharmacol Exp Ther (2001) 0.78
Spectrum and subcellular determinants of fluorinated anesthetic-mediated proximal tubular injury. Am J Pathol (1997) 0.78
Loss of function of the tissue specific transcription factor HNF1 alpha in renal cell carcinoma and clinical prognosis. Anticancer Res (1999) 0.78
Human reductive halothane metabolism in vitro is catalyzed by cytochrome P450 2A6 and 3A4. Drug Metab Dispos (1996) 0.78
Plasma levels of 2% lidocaine with 1:100,000 epinephrine with young children undergoing dental procedures. Anesth Prog (1998) 0.78
[Nutrition, lifestyle, physical activity, and supportive care during chemotherapeutic treatment]. Urologe A (2006) 0.78
Designing safer chemicals: predicting the rates of metabolism of halogenated alkanes. Proc Natl Acad Sci U S A (1995) 0.78
Determination of alfentanil and noralfentanil in human plasma by gas chromatography-mass spectrometry. J Chromatogr B Biomed Appl (1994) 0.78
1-[Carbon-11]-glucose radiation dosimetry and distribution in human imaging studies. J Nucl Med (1998) 0.78
Successful pharmacologic treatment of massive atenolol overdose: sequential hemodynamics and plasma atenolol concentrations. Anesthesiology (1995) 0.77